Showing results (261-270 of 308) with videos related to
Sort By:
Pageof 31
Yonsei Medical Journal|August 11, 2015
Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular CarcinomaSeung Up Kim, Jeon Han Park, Hyon-Suk Kim, et al.Plos One|September 1, 2015
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug ResistanceSung Hyun Ahn, Doo Hyun Kim, Ah Ram Lee, et al.Journal of Gastroenterology and Hepatology|April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated CirrhosisNobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.Gastroenterology|July 5, 2022
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual ParticipantsVeeral Ajmera, Beom Kyung Kim, Kun Yang, et al.Journal of Korean Medical Science|April 27, 2021
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic PatientsDavid Sooik Kim, Soo Young Park, Beom Kyung Kim, et al.Journal of Gastroenterology and Hepatology|May 1, 2014
Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigensBeom Kyung Kim, Sung Hoon Choi, Sung Hyun Ahn, et al.Clinical and Molecular Hepatology|March 12, 2024
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world studyYoung Eun Chon, Dong Yun Kim, Mi Na Kim, et al.European Journal of Gastroenterology & Hepatology|February 4, 2020
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis CHo Soo Chun, Beom Kyung Kim, Jun Yong Park, et al.Gut and Liver|July 9, 2021
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver DiseaseYuna Kim, Eugene Han, Jae Seung Lee, et al.Journal of Cancer Research and Clinical Oncology|April 24, 2021
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinomaSojung Han, Hye Jin Choi, Seung-Hoon Beom, et al.Pageof 31